Laila Tabatabai, MD
Endocrinology, Diabetes & Metabolism · Houston, TXNPI 1477788214
Payments from drug & device makers
Across 540 payments — averaging $1445.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$395K
- Ultragenyx Pharmaceutical Inc.$243K
- Amgen$96K
- Radius Health, Inc.$45K
- Abbott$359
- Lilly USA, LLC$276
- plus $836 from 12 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 111 | $394,747 |
| Ultragenyx Pharmaceutical Inc. | 95 | $243,300 |
| Amgen(2 entities) | 198 | $95,763 |
| Radius Health, Inc. | 79 | $45,196 |
| Abbott | 15 | $359 |
| Lilly USA, LLC | 13 | $276 |
| AstraZeneca | 3 | $224 |
| Xeris Pharmaceuticals, Inc. | 7 | $133 |
| AbbVie | 6 | $125 |
| Ascendis Pharma Endocrinology Inc | 1 | $124 |
| Novo Nordisk | 4 | $85 |
| IBSA Pharma Inc. | 2 | $30 |
| Ascensia Diabetes Care US Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Alvogen Inc | 1 | $12 |
How this compares
$780,477 in reported general payments places this provider in the 90th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Houston
- Maria CabanillasHouston$16.4M
- Damaris VegaHouston$12.3M
- Amer Al KaradshehHouston$8.8M
- Amir HassanHouston$5.2M
- Camilo JimenezHouston$5M
- Rocio HarbisonHouston$3.2M
- Gerardo BuesoHouston$1.2M
- Veena WatweHouston$976K
- Andres SplenserHouston$923K
- Prashant KoshyHouston$795K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.